<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ghini V</submitter><funding>Regione Toscana</funding><pagination>e1010443</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9022834</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(4)</volume><pubmed_abstract>Metabolomics and lipidomics have been used in several studies to define the biochemical alterations induced by COVID-19 in comparison with healthy controls. Those studies highlighted the presence of a strong signature, attributable to both metabolites and lipoproteins/lipids. Here, 1H NMR spectra were acquired on EDTA-plasma from three groups of subjects: i) hospitalized COVID-19 positive patients (≤21 days from the first positive nasopharyngeal swab); ii) hospitalized COVID-19 positive patients (>21 days from the first positive nasopharyngeal swab); iii) subjects after 2-6 months from SARS-CoV-2 eradication. A Random Forest model built using the EDTA-plasma spectra of COVID-19 patients ≤21 days and Post COVID-19 subjects, provided a high discrimination accuracy (93.6%), indicating both th</pubmed_abstract><journal>PLoS pathogens</journal><pubmed_title>Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.</pubmed_title><pmcid>PMC9022834</pmcid><funding_grant_id>project COMETA, Bando COVID-19</funding_grant_id><pubmed_authors>Meoni G</pubmed_authors><pubmed_authors>Luchinat C</pubmed_authors><pubmed_authors>Landini G</pubmed_authors><pubmed_authors>Pelagatti L</pubmed_authors><pubmed_authors>Ghini V</pubmed_authors><pubmed_authors>Celli T</pubmed_authors><pubmed_authors>Bertini L</pubmed_authors><pubmed_authors>Veneziani F</pubmed_authors><pubmed_authors>Petrucci F</pubmed_authors><pubmed_authors>Vannucchi V</pubmed_authors><pubmed_authors>Turano P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients.</name><description>Metabolomics and lipidomics have been used in several studies to define the biochemical alterations induced by COVID-19 in comparison with healthy controls. Those studies highlighted the presence of a strong signature, attributable to both metabolites and lipoproteins/lipids. Here, 1H NMR spectra were acquired on EDTA-plasma from three groups of subjects: i) hospitalized COVID-19 positive patients (≤21 days from the first positive nasopharyngeal swab); ii) hospitalized COVID-19 positive patients (>21 days from the first positive nasopharyngeal swab); iii) subjects after 2-6 months from SARS-CoV-2 eradication. A Random Forest model built using the EDTA-plasma spectra of COVID-19 patients ≤21 days and Post COVID-19 subjects, provided a high discrimination accuracy (93.6%), indicating both th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-19T00:39:37.787Z</modification><creation>2025-04-07T11:45:44.274Z</creation></dates><accession>S-EPMC9022834</accession><cross_references><pubmed>35446921</pubmed><doi>10.1371/journal.ppat.1010443</doi></cross_references></HashMap>